Phibro Animal Health (PAHC) Gross Profit Margin: History & Chart

Phibro Animal Health Corporation(PAHC)

Drug Manufacturers - Specialty & Generic · Teaneck, NJ

$36.64-0.55 (-1.48%)

Delayed quote: Oct 6, 2026, 2:50 PM EDT

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Teaneck, NJ

2,605 employees

www.pahc.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Daniel Bendheim

View full financials

PAHC Gross Margin Metrics

GROSS MARGIN

33.71%

GROSS MARGIN AVG TTM

32.78%

GROSS MARGIN AVG 3Y

31.68%

GROSS MARGIN AVG 5Y

31.06%

GROSS MARGIN AVG 10Y

31.78%

GROSS MARGIN AVG 15Y

31.56%

GROSS MARGIN AVG 20Y

30.16%

CURRENT VS TTM AVG

+2.85%

CURRENT VS 3Y AVG

+6.40%

CURRENT VS 5Y AVG

+8.55%

CURRENT VS 10Y AVG

+6.07%

CURRENT VS 15Y AVG

+6.81%

CURRENT VS 20Y AVG

+11.78%

SECTOR MEDIAN · HEALTHCARE

41.38%

median of 863 covered companies

CURRENT VS SECTOR MEDIAN

-18.54%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
Phibro Animal Health Corporation (PAHC)	$1.49B	33.71%	32.78%	31.68%	31.06%
Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›	$1.47B	0.00%	0.00%	0.00%	0.00%
GH Research PLC (GHRS)vs ›	$1.47B	0.00%	0.00%	0.00%	0.00%
Eton Pharmaceuticals, Inc. (ETON)vs ›	$1.51B	57.87%	56.73%	61.85%	-49.66%
Certara, Inc. (CERT)vs ›	$1.45B	58.33%	60.70%	60.53%	60.29%
Maze Therapeutics, Inc. (MAZE)vs ›	$1.46B	0.00%	50.00%	25.00%	25.00%
Nutex Health, Inc. (NUTX)vs ›	$1.53B	51.26%	45.83%	28.18%	37.38%
Ultragenyx Pharmaceutical Inc. (RARE)vs ›	$1.44B	83.12%	85.05%	87.98%	90.85%
Healthcare Services Group, Inc. (HCSG)vs ›	$1.44B	17.33%	13.16%	12.65%	13.31%
Syndax Pharmaceuticals, Inc. (SNDX)vs ›	$1.54B	97.47%	96.23%	48.12%	65.41%

NAME

MARKET CAP

GROSS MARGIN

TTM

Phibro Animal Health Corporation (PAHC)

$1.49B

33.71%

32.78%

31.68%

31.06%

Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›

$1.47B

0.00%

GH Research PLC (GHRS)vs ›

$1.47B

0.00%

Eton Pharmaceuticals, Inc. (ETON)vs ›

$1.51B

57.87%

56.73%

61.85%

-49.66%

Certara, Inc. (CERT)vs ›

$1.45B

58.33%

60.70%

60.53%

60.29%

Maze Therapeutics, Inc. (MAZE)vs ›

$1.46B

0.00%

50.00%

25.00%

Nutex Health, Inc. (NUTX)vs ›

$1.53B

51.26%

45.83%

28.18%

37.38%

Ultragenyx Pharmaceutical Inc. (RARE)vs ›

$1.44B

83.12%

85.05%

87.98%

90.85%

Healthcare Services Group, Inc. (HCSG)vs ›

$1.44B

17.33%

13.16%

12.65%

13.31%

Syndax Pharmaceuticals, Inc. (SNDX)vs ›

$1.54B

97.47%

96.23%

48.12%

65.41%

Gross Margin FAQ

What is the gross margin for Phibro Animal Health Corporation (PAHC)?

The gross margin for PAHC stock is 33.71%.

Is Phibro Animal Health Corporation's gross margin high or low?

The gross margin of 33.71% is in line with its 5-year average of 31.06%, near the high end of its 5-year range (29.05%–35.48%).

What is the TTM average gross margin for Phibro Animal Health Corporation (PAHC)?

The TTM average gross margin for PAHC stock is 32.78%.

What is the 3Y average gross margin for Phibro Animal Health Corporation (PAHC)?

The 3Y average gross margin for PAHC stock is 31.68%.

What is the 5Y average gross margin for Phibro Animal Health Corporation (PAHC)?

The 5Y average gross margin for PAHC stock is 31.06%.

What is the 10Y average gross margin for Phibro Animal Health Corporation (PAHC)?

The 10Y average gross margin for PAHC stock is 31.78%.

What is the 15Y average gross margin for Phibro Animal Health Corporation (PAHC)?

The 15Y average gross margin for PAHC stock is 31.56%.

What is the 20Y average gross margin for Phibro Animal Health Corporation (PAHC)?

The 20Y average gross margin for PAHC stock is 30.16%.

DATE	GROSS MARGIN
2026-06-30	33.88%
2026-03-31	32.56%
2025-12-31	35.48%
2025-09-30	32.92%
2025-06-30	29.05%
2025-03-31	30.06%
2024-12-31	32.94%
2024-09-30	32.06%
2024-06-30	31.90%
2024-03-31	30.24%
2023-12-31	31.45%
2023-09-30	29.27%
2023-06-30	30.06%
2023-03-31	30.75%
2022-12-31	31.63%
2022-09-30	29.52%
2022-06-30	30.72%
2022-03-31	29.89%
2021-12-31	30.37%
2021-09-30	30.13%
2021-06-30	31.70%
2021-03-31	32.67%
2020-12-31	33.11%
2020-09-30	32.85%
2020-06-30	32.58%
2020-03-31	33.00%
2019-12-31	32.29%
2019-09-30	30.39%
2019-06-30	32.03%
2019-03-31	31.53%
2018-12-31	31.46%
2018-09-30	32.88%
2018-06-30	31.87%
2018-03-31	33.06%
2017-12-31	32.50%
2017-09-30	32.77%
2017-06-30	32.39%
2017-03-31	31.93%
2016-12-31	33.14%
2016-09-30	32.45%
2016-06-30	31.50%
2016-03-31	32.68%
2015-12-31	32.55%
2015-09-30	32.15%
2015-06-30	32.90%
2015-03-31	31.53%
2014-12-31	29.72%
2014-09-30	32.18%
2014-06-30	29.56%
2014-03-31	30.50%
2013-12-31	29.61%
2013-09-30	30.52%
2013-06-30	29.33%
2013-03-31	28.13%
2012-12-31	26.31%
2012-09-30	26.07%
2009-12-31	26.68%
2009-09-30	26.49%
2009-06-30	27.97%
2009-03-31	22.56%
2008-12-31	23.73%
2008-09-30	22.47%
2008-06-30	23.94%
2008-03-31	22.96%
2007-12-31	23.62%
2007-09-30	24.87%
2007-06-30	24.27%
2007-03-31	24.26%
2006-12-31	26.24%
2006-09-30	23.19%
2006-06-30	25.95%
2006-03-31	24.28%
2005-12-31	20.26%
2005-09-30	20.73%
2005-06-30	17.65%
2005-03-31	20.82%
2004-12-31	14.67%
2004-09-30	25.55%
2004-06-30	25.00%
2004-03-31	26.51%
2003-12-31	24.37%
2003-09-30	24.94%
2003-06-30	27.81%
2003-03-31	25.83%
2002-12-31	26.64%
2002-09-30	25.72%

DATE

GROSS MARGIN

2026-06-30

33.88%

2026-03-31

32.56%

2025-12-31

35.48%

2025-09-30

32.92%

2025-06-30

29.05%

2025-03-31

30.06%

2024-12-31

32.94%

2024-09-30

32.06%

2024-06-30

31.90%

2024-03-31

30.24%

2023-12-31

31.45%

2023-09-30

29.27%

2023-06-30

30.06%

2023-03-31

30.75%

2022-12-31

31.63%

2022-09-30

29.52%

2022-06-30

30.72%

2022-03-31

29.89%

2021-12-31

30.37%

2021-09-30

30.13%

2021-06-30

31.70%

2021-03-31

32.67%

2020-12-31

33.11%

2020-09-30

32.85%

2020-06-30

32.58%

2020-03-31

33.00%

2019-12-31

32.29%

2019-09-30

30.39%

2019-06-30

32.03%

2019-03-31

31.53%

2018-12-31

31.46%

2018-09-30

32.88%

2018-06-30

31.87%

2018-03-31

33.06%

2017-12-31

32.50%

2017-09-30

32.77%

2017-06-30

32.39%

2017-03-31

31.93%

2016-12-31

33.14%

2016-09-30

32.45%

2016-06-30

31.50%

2016-03-31

32.68%

2015-12-31

32.55%

2015-09-30

32.15%

2015-06-30

32.90%

2015-03-31

31.53%

2014-12-31

29.72%

2014-09-30

32.18%

2014-06-30

29.56%

2014-03-31

30.50%

2013-12-31

29.61%

2013-09-30

30.52%

2013-06-30

29.33%

2013-03-31

28.13%

2012-12-31

26.31%

2012-09-30

26.07%

2009-12-31

26.68%

2009-09-30

26.49%

2009-06-30

27.97%

2009-03-31

22.56%

2008-12-31

23.73%

2008-09-30

22.47%

2008-06-30

23.94%

2008-03-31

22.96%

2007-12-31

23.62%

2007-09-30

24.87%

2007-06-30

24.27%

2007-03-31

24.26%

2006-12-31

26.24%

2006-09-30

23.19%

2006-06-30

25.95%

2006-03-31

24.28%

2005-12-31

20.26%

2005-09-30

20.73%

2005-06-30

17.65%

2005-03-31

20.82%

2004-12-31

14.67%

2004-09-30

25.55%

2004-06-30

25.00%

2004-03-31

26.51%

2003-12-31

24.37%

2003-09-30

24.94%

2003-06-30

27.81%

2003-03-31

25.83%

2002-12-31

26.64%

2002-09-30

25.72%

Gross Margin: 33.71%

PAHC Gross Margin

PAHC Average Gross Margin Chart

PAHC Current vs Average Gross Margin Chart

PAHC Gross Margin Metrics

PAHC Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

PAHC Gross Margin History

Related Metrics